Cargando…

The commercialization of university-based research: Balancing risks and benefits

BACKGROUND: The increasing push to commercialize university research has emerged as a significant science policy challenge. While the socio-economic benefits of increased and rapid research commercialization are often emphasized in policy statements and discussions, there is less mention or discussi...

Descripción completa

Detalles Bibliográficos
Autores principales: Caulfield, Timothy, Ogbogu, Ubaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605102/
https://www.ncbi.nlm.nih.gov/pubmed/26464028
http://dx.doi.org/10.1186/s12910-015-0064-2
_version_ 1782395166899830784
author Caulfield, Timothy
Ogbogu, Ubaka
author_facet Caulfield, Timothy
Ogbogu, Ubaka
author_sort Caulfield, Timothy
collection PubMed
description BACKGROUND: The increasing push to commercialize university research has emerged as a significant science policy challenge. While the socio-economic benefits of increased and rapid research commercialization are often emphasized in policy statements and discussions, there is less mention or discussion of potential risks. In this paper, we highlight such potential risks and call for a more balanced assessment of the commercialization ethos and trends. DISCUSSION: There is growing evidence that the pressure to commercialize is directly or indirectly associated with adverse impacts on the research environment, science hype, premature implementation or translation of research results, loss of public trust in the university research enterprise, research policy conflicts and confusion, and damage to the long-term contributions of university research. SUMMARY: The growing emphasis on commercialization of university research may be exerting unfounded pressure on researchers and misrepresenting scientific research realities, prospects and outcomes. While more research is needed to verify the potential risks outlined in this paper, policy discussions should, at a minimum, acknowledge them.
format Online
Article
Text
id pubmed-4605102
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46051022015-10-15 The commercialization of university-based research: Balancing risks and benefits Caulfield, Timothy Ogbogu, Ubaka BMC Med Ethics Debate BACKGROUND: The increasing push to commercialize university research has emerged as a significant science policy challenge. While the socio-economic benefits of increased and rapid research commercialization are often emphasized in policy statements and discussions, there is less mention or discussion of potential risks. In this paper, we highlight such potential risks and call for a more balanced assessment of the commercialization ethos and trends. DISCUSSION: There is growing evidence that the pressure to commercialize is directly or indirectly associated with adverse impacts on the research environment, science hype, premature implementation or translation of research results, loss of public trust in the university research enterprise, research policy conflicts and confusion, and damage to the long-term contributions of university research. SUMMARY: The growing emphasis on commercialization of university research may be exerting unfounded pressure on researchers and misrepresenting scientific research realities, prospects and outcomes. While more research is needed to verify the potential risks outlined in this paper, policy discussions should, at a minimum, acknowledge them. BioMed Central 2015-10-14 /pmc/articles/PMC4605102/ /pubmed/26464028 http://dx.doi.org/10.1186/s12910-015-0064-2 Text en © Caulfield and Ogbogu. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Debate
Caulfield, Timothy
Ogbogu, Ubaka
The commercialization of university-based research: Balancing risks and benefits
title The commercialization of university-based research: Balancing risks and benefits
title_full The commercialization of university-based research: Balancing risks and benefits
title_fullStr The commercialization of university-based research: Balancing risks and benefits
title_full_unstemmed The commercialization of university-based research: Balancing risks and benefits
title_short The commercialization of university-based research: Balancing risks and benefits
title_sort commercialization of university-based research: balancing risks and benefits
topic Debate
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605102/
https://www.ncbi.nlm.nih.gov/pubmed/26464028
http://dx.doi.org/10.1186/s12910-015-0064-2
work_keys_str_mv AT caulfieldtimothy thecommercializationofuniversitybasedresearchbalancingrisksandbenefits
AT ogboguubaka thecommercializationofuniversitybasedresearchbalancingrisksandbenefits
AT caulfieldtimothy commercializationofuniversitybasedresearchbalancingrisksandbenefits
AT ogboguubaka commercializationofuniversitybasedresearchbalancingrisksandbenefits